CytomX Therapeutics (NasdaqGS:CTMX) 2026 Conference Transcript

CytomX Therapeutics (NasdaqGS:CTMX) 2026 Conference February 11, 2026 04:30 PM ET Company ParticipantsChris Ogden - CFOConference Call ParticipantsMichael Schmidt - Senior Biotech AnalystMichael Schmidtthis next fireside chat. My name is Michael Schmidt, Senior Biotech Analyst with Guggenheim, and it's my great pleasure to welcome Chris Ogden, Chief Financial Officer of CytomX. So CytomX is a new coverage here, new research coverage at Guggenheim for us. It's a story we're really excited about, especially t ...